The value of using the xenogeneic bone substitute Bio-Oss ® and a collagen membrane for guided bone regeneration (GBR) was evaluated. Five-millimeter bone defects were created in the cranial bones of 15, 15-week-old, male Sprague-Dawley rats, fi ve of which were left unfi lled (Group A), fi ve were fi lled with Bio-Oss ® (Group B), and fi ve were fi lled with Bio